How to Buy Harvard Bioscience Stock
Harvard Bioscience Inc
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally.
Harvard Bioscience stock last closed at $0.36, down 6.19% from the previous day, and has decreased 90.16% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.78 percentage points. Harvard Bioscience stock is currently +2.54% from its 52-week low of $0.36, and -91.08% from its 52-week high of $4.08.
At the moment, there are 44.07M shares of HBIO outstanding. The market value of HBIO is $16.04M. In the past 24 hours, 394,568 HBIO shares were traded.
How to Buy Harvard Bioscience Stock
Wondering how to invest in Harvard Bioscience stock? Here's how.
- Choose where to buy Harvard Bioscience stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you figure out where to buy Harvard Bioscience stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your method of payment and add your details.
- Analyze Harvard Bioscience stock: The Harvard Bioscience ticker symbol is HBIO. Is Harvard Bioscience stock a good investment? Should you buy shares of HBIO? How do HBIO's underlying business fundamentals look? Do top analysts think Harvard Bioscience is a good buy? Why has HBIO's stock price moved recently? (Hint: Our stock research tools can help you understand if HBIO is a good stock to buy).
- Make your HBIO buy order: Decide if you will purchase HBIO shares at the current market price or use a limit order to purchase HBIO stock at a specific price.
- Get updates on your investment in HBIO: Create a watchlist to get live updates on your position in Harvard Bioscience shares.
Step 1: Choose where to buy Harvard Bioscience stock
You need an online brokerage account to access the NASDAQ market and buy HBIO shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the best brokerage, you need to fill out some personal info so you can invest in HBIO stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've opened your account on the best stock broker app, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help transferring funds into your brokerage account.
Step 4: Analyze Harvard Bioscience stock
Once you have figured out the best place to buy Harvard Bioscience stock, it's absolutely critical to research their stock prior to investing, so you truly understand the risk as well as the upside.
Harvard Bioscience shares data
Harvard Bioscience Due Diligence Checks
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on HBIO's stock page.
What is the fair value of HBIO stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge HBIO's fair value.
Using relative valuations ratios:
- HBIO could be undervalued based on its P/B ratio of 0.25x, relative to Medical Instruments & Supplies industry P/B ratio of 3.49x
You can access more valuation analysis on HBIO's stock here.
HBIO Financials at a glance
Positive Health Checks:
- There are more short-term assets than long-term liabilities on the HBIO balance sheet.
- HBIO has $4.11M in cash and short term investments. This is enough to cover its annual cash burn of $1.82M.
- Total HBIO debt is lower than 5 years ago, relative to shareholder equity.
- HBIO has cash burn of 1823000. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- There are more short-term liabilities than short-term assets on the HBIO balance sheet.
- HBIO has a relatively high debt to equity ratio of 1.
- HBIO profit margin has gone down from -3% to -13.2% in the past year.
Is Harvard Bioscience stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Wall Street analysts who give ratings on HBIO, the consensus analyst rating on Harvard Bioscience is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Harvard Bioscience stock forecast page.
HBIO Trading Indicators
HBIO Growth Metrics
Last year, HBIO revenue was $94.14M. Over the past five year, HBIO's revenue has increased by -4.12% per year. This was slower than the Medical Instruments & Supplies industry average of 8.96%.
Find out more about HBIO's earnings and revenue performance here.
Latest Insiders Trades at HBIO
In the last year, executives and large shareholders at HBIO have sold more shares than they have bought.
Jennifer Cote, Chief Financial Officer of HBIO, was the latest HBIO insider to sell. They sold $3,918.34 worth of HBIO stock on Mar 19, 2025.
Dig into more about who owns HBIO stock here.
Can I get consistent income from HBIO stock?
No, Harvard Bioscience doesn't provide an income stream by paying out dividends.
What others are saying about HBIO
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your HBIO buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at an exact price, use a limit order.
Hit the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, click the how to video below:
Step 6: Get updates on your investment in HBIO
Now that you own some shares in HBIO, you'll want to stay up-to-date on your shares.
Create a watchlist to track the most important metrics related to your HBIO stock.
HBIO Feed
How to Buy Stock in Harvard Bioscience
To summarize, here are the 6 steps you need to take to buy Harvard Bioscience stock right now:
- Choose where to buy Harvard Bioscience stock
- Open your brokerage account
- Fund your investment account
- Analyze Harvard Bioscience stock
- Make your HBIO buy order
- Get updates on your investment in HBIO
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Harvard Bioscience, hit the button below to create your watchlist.
More Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.